1. Home
  2. Live Updates
  3. Sandeep sewlikar

Live Breaking News & Updates on Sandeep sewlikar

Stay informed with the latest breaking news from Sandeep sewlikar on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sandeep sewlikar and stay connected to the pulse of your community

Driving Cervical Cancer Elimination in Sri Lanka - Adaderana Biz English

Cervical cancer ranks as the second most common cancer among women in Sri Lanka, accounting for an estimated 1,407 diagnoses and 780 deaths each year.1 Without intervention, projections forecast a potential death toll of 58,754 by 2070 and 115,137 by 2120.2 Addressing this urgent need to eliminate cervical cancer , a panel discussion was convened...

Sri-lanka , Kalutara , Western , Colombo , Padmaka-silva , Nirmali-samaratunga , Ramani-punchihewa , Sandeep-sewlikar , Intraepithelial-neoplasia , J-padmaka-silva , Ministry-of-health-sri-lanka , National-hospital-for-respiratory-disease

Voluntary Blood Donation Day: Significance, benefits of voluntary blood donation | Health

Voluntary blood donation can not only save lives and help manage several disorders but also help the donor in a number of ways. | Health

India , Hindustan , India-general- , Sandeep-sewlikar , Vasant-kunj , Tushar-tayal , Regulatory-affairs , Blood-transfusion-councils , Indian-society-of-blood-transfusion , Journal-of-the-national-cancer-institute , National-voluntary-blood-donation-day , Indian-society

Roche Diagnostics introduces a dual antigen and antibody diagnostic test in India

Roche Diagnostics India announced the launch of the Elecsys HCV Duo which is India’s first commercially available fully...

India , Sandeep-sewlikar , European-association-for-study-of-liver , National-viral-hepatitis-control-program , Diagnostics-india , Medical-affair , Roche-diagnostics , European-association , Diagnostics- ,

Adyar Institute Unveils Impact of HPV Molecular Testing in Cervical Cancer Community Screening Program in South India

Adyar Institute Unveils Impact of HPV Molecular Testing in Cervical Cancer Community Screening Program in South India
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

Nepal , India , Adyar , Tamil-nadu , Sri-lanka , Tuticorin , Bhutan , Thoothukudi , Chennai , Jayashree-natarajan , Komathi-arun , Banumathy-satyaseelan

Adyar Institute Unveils Impact of HPV molecular testing in cervical cancer community screening program in South India – Chennaionline

Adyar Institute Unveils Impact of HPV molecular testing in cervical cancer community screening program in South India – Chennaionline
chennaionline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chennaionline.com Daily Mail and Mail on Sunday newspapers.

Tuticorin , Tamil-nadu , India , Chennai , Adyar , Sri-lanka , Thoothukudi , Nepal , Bhutan , Vijayalakshmi-ramshankar , Lalitha-ramasubramanian , Komathi-arun

Roche Diagnostics launches Elecsys Anti-SARS-CoV-2 S test in India

The Elecsys Anti-SARS-CoV-2 S targets antibodies, which are directed against the particular region of the viral spike protein responsible for binding to the host cell receptor, which is required for the virus to enter the host cell


India , Narendra-varde , Sandeep-sewlikar , Head-of-medical-scientific-affairs , Roche-diagnostics-india , Managing-director , Scientific-affairs , Roche-diagnostics , Sars-cov-2-test , Elecsys-anti-sars-cov-2-s , Icmr , Cdsco

Roche Diagnostics launches Elecsys Anti-SARS-CoV-2 S in India


Roche Diagnostics launches Elecsys Anti-SARS-CoV-2 S test in India
Roche Diagnostics launches Elecsys Anti-SARS-CoV-2 S test in India
22 January 2021 | News
The Elecsys Anti-SARS-CoV-2 S targets antibodies which are directed against the particular region of the viral spike protein
Source: diagnostics.roche.com
Roche Diagnostics India has announced the launch of its antibody test SARS-CoV-2 test-Elecsys Anti-SARS-CoV-2 S. The test is CE IVD approved and has received ICMR and CDSCO approval in India. It is an in vitro test, that quantifies antibodies against the receptor-binding domain (RBD) of spike (S) protein SARS-CoV-2 in human serum and plasma, and determines the body’s immune response to the virus.

India , Narendra-varde , Sandeep-sewlikar , Head-of-medical-scientific-affairs , Roche-diagnostics-india , Managing-director , Scientific-affairs , இந்தியா , நரேந்திர-வர்தே , தலை-ஆஃப்-மருத்துவ-அறிவியல்-வாழ்க்கைத்தொழில்கள் , ரோச்-பரிசோதனை-இந்தியா , நிர்வகித்தல்-இயக்குனர்